Imiquimod therapy after surgical removal of anal HPV-lesions to reduce likelihood of recurrence
Phase 1
- Conditions
- anal HPV-lesionsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Registration Number
- EUCTR2017-000842-23-AT
- Lead Sponsor
- Medical University Innsbruck
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- age >=18 years
- Indication of surgical sanitation of HPV-lesions in anal area by means of fulguration
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 150
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50
Exclusion Criteria
- participation in other trials
- diagnosis of HPV-associated lesions in the last 12 month
- known allergy to Imiquimod
- pregnant of lactating women
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method